SCHEMBL4718005

SCHEMBL4718005

Cc1c[nH]c(CCc2ccccc2)nc1=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DAO P14920 4/20 0.44
GSK3B P49841 1/20 0.43
RAB9A P51151 2/20 0.41
NPC1 O15118 1/20 0.41
RNASEH1 O60930 1/20 0.41
ALPL P05186 1/20 0.40
TAAR1 Q96RJ0 1/20 0.40
TUBB4A P04350 1/20 0.40
TUBB P07437 1/20 0.40
TUBA3C P0DPH7 1/20 0.40
TUBA1B P68363 1/20 0.40
TUBA4A P68366 1/20 0.40
TUBB4B P68371 1/20 0.40
TUBB3 Q13509 1/20 0.40
TUBB2A Q13885 1/20 0.40
TUBB8 Q3ZCM7 1/20 0.40
TUBA3E Q6PEY2 1/20 0.40
TUBA1A Q71U36 1/20 0.40
TUBA1C Q9BQE3 1/20 0.40
TUBB6 Q9BUF5 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8958095 0.80 RAB9A (0.46) DAORAB9ANPC1RNASEH1TAAR1
SCHEMBL10704195 0.73 RAB9A (0.46) DAORAB9ANPC1TAAR1ALDH1A1
SCHEMBL9596390 0.73 RAB9A (0.46) DAORAB9ANPC1RNASEH1ALPL
SCHEMBL28845716 0.72 RAB9A (0.42) DAORAB9ANPC1TAAR1ALDH1A1
SCHEMBL27608302 0.72 RAB9A (0.42) DAOGSK3BRAB9ANPC1RNASEH1
SCHEMBL948426 0.72 RNASEH1 (0.49) DAORAB9ANPC1RNASEH1TAAR1
SCHEMBL12068347 0.71 GSK3B (0.49) DAOGSK3BRAB9ANPC1RNASEH1
SCHEMBL10144381 0.70 DAO (0.44) DAOGSK3B
SCHEMBL949159 0.70 MMP2 (0.56) RNASEH1ALDH1A1
SCHEMBL28356850 0.69 SMN1; SMN2 (0.48) DAORAB9ANPC1RNASEH1TAAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1337517-B1 PYRIMIDINONE DERIVATIVES AND THEIR USE IN THE TREATMENT OF ATHEROSCLEROSIS SMITHKLINE BEECHAM PLC (GB) 2008-11-26 EP disclosed
EP-1337517-A1 PYRIMIDINONE DERIVATIVES AND THEIR USE IN THE TREATMENT OF ATHEROSCLEROSIS SMITHKLINE BEECHAM PLC (GB) 2003-08-27 EP disclosed
WO-2002030911-A1 PYRIMIDINONE DERIVATIVES AND THEIR USE IN THE TREATMENT OF ATHEROSCLEROSIS SMITHKLINE BEECHAM P.L.C. (GB) 2002-04-18 WO disclosed